Global Vaccine Market Projected to Garner Significant Revenues by 2014 – 2020

Vaccination has been approved as one of the best methods for the prevention of infectious diseases by many international organizations such as the World Health Organization (WHO). The rising prevalence of diseases plays a central role in the growth of the global market for vaccines. Governments worldwide are striving to ensure good health of the people in their country.

Therefore, there is a strong demand for vaccines from government bodies, various advisory and regulatory bodies that keep a check on vaccine safety and quality, pooled procurement agencies, and private sectors. Some of the vaccinations available in the market are human papillomavirus (HPV), Hepatitis A and B, influenza, meningococcal, combination vaccines, and pneumococcal.

The research report takes into account the historic and current scenario to estimate trends of the global vaccine market in the foreseeable future. It offers insights into statistics and dynamics pertaining to the market at both global and regional level. For a better understanding, the report segments the market on the basis of various criteria such as products and antigens. It provides a detailed analysis of the competitive landscape of the market. It profiles the key players in the market along with their market shares, latest developments, business strategies, and contact information.

Read Report Overview @ https://www.transparencymarketresearch.com/global-vaccine-market.html

Global Vaccine Market: Drivers and Restraints

Over the past few years, the global vaccine market has exhibited tremendous growth and is likely to progress at a similar pace for the forthcoming years. The low risk of serious side effects associated with vaccines is resulting in a positive response from diverse demographics. Vaccine manufacturers are working towards the improvement of existing vaccines as well as the development of new vaccines, which is also providing a significant push to the market.

However, manufacturers have to invest considerable capital and undergo stringent regulatory approval processes for the development and approval of new vaccines. The handling, storage, and transportation of vaccines involve high cost. Moreover, the global vaccine market is highly dependent on donor policies and public purchasers, which amplifies the complexity of assessing and understanding pricing and procurement.

Global Vaccine Market: Regional Segmentation

The key regions methodically examined in the research report are North America, Asia Pacific, Europe, and Rest of the World. North America will be a lucrative market throughout the forecast horizon. The growth of the region can be attributed to the increasing initiatives by governments for immunization against diseases such as HPV and influenza along with a large number of private and public organizations pouring funds into the research and development of novel vaccines. Moreover, the presence of advanced and well-established healthcare infrastructure and facilities is providing a fillip to the growth of the region.

Asia Pacific is anticipated to rise at a noteworthy CAGR during the same period, primarily owing to the expanding base of patients coupled with high unmet clinical needs. Emerging countries such as China and India will be the major revenue contributors to the growth of the region. The rising disposable income and growing awareness regarding the benefits of vaccines are fuelling the growth of the region.

Global Vaccine Market: Competitive Landscape

The strong foothold of players such as Pfizer Inc., GlaxoSmithKline Plc., Novartis AG, and Sanofi is making the global vaccine market a highly concentrated arena. Several key players are focusing on mergers and acquisitions to expand their business across different regions. The continuous efforts by them to develop new and effective vaccines is intensifying the competitive rivalry in the market.

Request for Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=21

The market is highly regulated and capital intensive, which is creating high entry barriers for new players. Some other prominent players in the global vaccines market are Boehringer Ingelheim, Emergent Biosolutions Inc., Bavarian Nordic, Medimmune LLC., Merck & Co. Inc., CSL Ltd., and Zoetis Inc.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com

This release was published on openPR.